Filana Therapeutics (SAVA) Q1 2025 Earnings

3MarConfirmed
Q2 2024
Q3 2024
Q3 2024
Q1 2025
-0.88
-0.54
-0.21
0.13

Details

Expected EPS
-0.583333
Actual EPS
-0.57
Surprise EPS
0.01
Surprise Percent
+2.29%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.57 per share for Q1 2025.

0 Comments

Share your thoughts